Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Immune thrombocytopenic purpura in a patient with multiple sclerosis treated with natalizumab.

Stosic M, De Jesus P, McCarthy J, Hutton G, Rivera V.

Neurology. 2011 Aug 2;77(5):505-7. doi: 10.1212/WNL.0b013e318227b23f. No abstract available.

PMID:
21775738
2.

Severe infectious complications in a patient treated with rituximab for idiopathic thrombocytopenic purpura.

Fianchi L, Rossi E, Murri R, De Stefano V, Pagano L, Leone G.

Ann Hematol. 2007 Mar;86(3):225-6. No abstract available.

PMID:
17031685
3.

Successful treatment of refractory immune thrombocytopenia with anti-CD20 antibody in a patient with systemic lupus erythematosus.

Lee JW, Kim HA, Sung JM, Suh CH.

Lupus. 2010 Feb;19(2):227-8. doi: 10.1177/0961203309345723. No abstract available.

PMID:
19884220
4.

Rituximab efficacy in CIDP associated with idiopathic thrombocytopenic purpura.

Benedetti L, Franciotta D, Beronio A, Cadenotti L, Gobbi M, Mancardi GL, Schenone A, Tartaglione A.

Muscle Nerve. 2008 Aug;38(2):1076-7. doi: 10.1002/mus.21073. No abstract available.

PMID:
18642360
5.

Rituximab for patients with idiopathic thrombocytopenic purpura.

Peñalver FJ, Cabrera JR.

Ann Intern Med. 2007 Aug 21;147(4):281; author reply 281-2. No abstract available.

PMID:
17709765
6.
7.

Slow responses to standard dose rituximab in immune thrombocytopenic purpura.

Kelly K, Gleeson M, Murphy PT.

Haematologica. 2009 Mar;94(3):443-4; author reply 444-5. doi: 10.3324/haematol.2008.001396. No abstract available.

8.

Rituximab treatment in refractory idiopathic thrombocytopenic purpura in children.

Roganovic J.

Eur J Pediatr. 2005 May;164(5):334. No abstract available.

PMID:
15711954
9.

[Rituximab treatment for immune thrombocytopenia associated with systemic lupus erythematosus].

Lehembre S, Macario-Barrel A, Musette P, Carvalho P, Joly P.

Ann Dermatol Venereol. 2006 Jan;133(1):53-5. French.

PMID:
16495854
10.

[Immunologic thrombocytopenic purpura: a revolution of biological therapy?].

Bierling P, Godeau B.

Rev Prat. 2009 May 20;59(5):606-7. French. No abstract available.

PMID:
19552194
11.

Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks.

Morrow SA, O'Connor PW, Polman CH, Goodman AD, Kappos L, Lublin FD, Rudick RA, Jurgensen S, Paes D, Forrestal F, Benedict RH.

Mult Scler. 2010 Nov;16(11):1385-92. doi: 10.1177/1352458510378021.

PMID:
20739335
12.
13.

Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.

Koulova L, Alexandrescu D, Dutcher JP, O'Boyle KP, Eapen S, Wiernik PH.

Am J Hematol. 2005 Jan;78(1):49-54.

14.

Hydrocephalus during natalizumab treatment.

Zecca C, Städler C, Gobbi C.

Neurol Sci. 2010 Oct;31(5):635-7. doi: 10.1007/s10072-010-0282-9.

PMID:
20454819
15.

New therapies for immune thrombocytopenic purpura.

Andemariam B, Bussel J.

Curr Opin Hematol. 2007 Sep;14(5):427-31. Review.

PMID:
17934347
16.

[Good response to treatment with rituximab in a child with refractory idiopathic thrombocytopenic purpura].

Fríguls-Francitorra B, Almazán-Castro F, Manchón GJ.

Med Clin (Barc). 2006 Sep 30;127(12):478-9. Spanish. No abstract available.

PMID:
17040639
17.

[Rituximab monoclonal antibody in the treatment of retractable idiopathic thrombocytopenic purpura--a case report].

Zhou N, Hua BL, Wang SJ, Zhu TN, Zhao YQ.

Zhonghua Yi Xue Za Zhi. 2005 Feb 16;85(6):432. Chinese. No abstract available.

PMID:
15854541
18.
19.

Immunoglobulin for concurrent Guillain-Barré and immune thrombocytopenic purpura.

Zeidman LA, Fahey CD, Grinblatt DL, Harsanyi K.

Pediatr Neurol. 2006 Jan;34(1):60-2.

PMID:
16376282
20.

Giant cell hepatitis and immune thrombocytopenic purpura: reversal of liver failure with rituximab therapy.

Shores D, Kobak G, Pegram LD, Whitington PF, Shneider BL.

J Pediatr Gastroenterol Nutr. 2012 Oct;55(4):e128-30. No abstract available.

PMID:
21921813
Items per page

Supplemental Content

Support Center